1. Home
  2. FORR vs BDSX Comparison

FORR vs BDSX Comparison

Compare FORR & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forrester Research Inc.

FORR

Forrester Research Inc.

N/A

Current Price

$6.37

Market Cap

106.6M

ML Signal

N/A

Logo Biodesix Inc.

BDSX

Biodesix Inc.

N/A

Current Price

$19.44

Market Cap

122.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FORR
BDSX
Founded
1983
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.6M
122.0M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
FORR
BDSX
Price
$6.37
$19.44
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
202.9K
149.3K
Earning Date
05-14-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$88,499,000.00
Revenue This Year
N/A
$23.35
Revenue Next Year
$1.38
$19.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.08
52 Week Low
$4.91
$0.25
52 Week High
$11.57
$18.99

Technical Indicators

Market Signals
Indicator
FORR
BDSX
Relative Strength Index (RSI) 47.40 83.18
Support Level $5.02 $6.33
Resistance Level $8.36 N/A
Average True Range (ATR) 0.42 1.78
MACD 0.12 0.50
Stochastic Oscillator 78.10 99.37

Price Performance

Historical Comparison
FORR
BDSX

About FORR Forrester Research Inc.

Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: